Table 2: Main clinical features in patients with OSA and in control subjects.
|
OSA (AHI ≥ 5) N = 55 |
Controls (AHI < 5) N = 10 |
P |
Age |
61.6 ± 11.4 |
57.1 ± 16.0 |
0.282 |
BMI |
30.1 ± 6.4 |
24.0 ± 5.3 |
0.005* |
Waist circumference |
102 [96-113] |
90 [85-100] |
0.006* |
Neck circumference |
41 [38-45] |
36 [32.75-39.50] |
0.002* |
Male |
70.9% |
40.0% |
0.057 |
Smoking |
9.1% |
10.0% |
0.927 |
Hypertension |
85.5% |
50.0% |
0.010* |
Diabetes |
30.9% |
0.0% |
0.041* |
Dyslipidemia |
63.6% |
50.0% |
0.489 |
Antiarrhythmic drugs |
25.5% |
20.0% |
0.713 |
Previous major adverse cardiac or cerebrovascular events |
20.0% |
10.0% |
0.453 |
SVES supraventricular extrasystoles (24 h) |
38 [16-250] |
13 [6.75-118.75] |
0.184 |
VES ventricular extrasystoles (24 h) |
35 [4-1090] |
1 [0-36.25] |
0.008* |